Ignite Planners
VRTX icon

Ignite Planners’s Vertex Pharmaceuticals VRTX Stock Holding History

Ignite Planners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$775K Buy
1,467
+114
+8% +$58.4K 0.1% 203
2026
Q2 		$673K Buy
1,353
+621
+85% +$275K 0.09% 217
2026
Q1 		$327K Buy
732
+65
+10% +$30.3K 0.05% 308
2025
Q4 		$313K Buy
+667
New +$287K 0.05% 320
2025
Q3 		– Sell
-462
Closed -$212K – 385
2025
Q2 		$212K Sell
462
-145
-24% -$66.8K 0.04% 340
2025
Q1 		$303K Buy
+607
New +$283K 0.06% 267

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Ignite Planners's VRTX Position: Q3 2026 in Review

Ignite Planners increased its Vertex Pharmaceuticals (VRTX) stake by 8.4% in Q3 2026, buying an estimated $58.4K and bringing the position to 1,467 shares worth $775K. The position accounts for 0.1% of the portfolio, ranked #203.

Ignite Planners first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 376 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Ignite Planners held 1,467 shares of Vertex Pharmaceuticals worth $775K as of Q3 2026.
  • Ignite Planners bought 114 Vertex Pharmaceuticals shares in Q3 2026, an estimated $58.4K.
  • Vertex Pharmaceuticals made up 0.1% of Ignite Planners's portfolio in Q3 2026, its #203 holding.
  • Ignite Planners first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 376 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Ignite Planners's 13F filing for Q3 2026, filed 14 Oct 2026.